DENVER, CO -- MAY 2, 2012 -- Dixie Elixirs and Edibles, Colorado’s premier Tetrahydrocannabinol or THC-infused products company, today announced a new line of products which will break entirely new ground for the company in the category of non THC-infused product development. Following closely on the heels of its’ acquisition by cannabis and hemp industry innovators, Medical Marijuana, Inc. (OTC: MJNA), today’s announcement consists of three new hemp-based Cannabidiol (CBD) products that contain no THC:
The Food and Drug Administration (FDA) currently considers hemp based cannabinoids, including CBD, to be “food based” and therefore legal without a medical marijuana license. Amongst the many potential uses for CBD-based products that are currently under evaluation, CBD’s have been shown torelieve convulsion, inflammation, anxiety, and nausea. Based on medical potential and the federally legal status of hemp-based CBD products, Dixie and Medical Marijuana, Inc., estimate the market in the U. S. to be well over $5 billion. These three new products are the first of many that the companies intend to bring to the market in the coming year.
Dixie will initially offer the new products exclusively to their existing customer base which consists of over 400 dispensaries in the state of Colorado. This consumer base represents in excess of 70 percent of the addressable medical marijuana market inColoradoand over nine percent of theU. S.medical cannabis market. Within 90 days the Company intends to launch a mail order campaign and online e-commerce platform that will allow individuals throughout the U. S. to purchase these products since they contain no THC. TheU. S.availability will be followed closely by distribution in international markets includingEuropevia several key product distribution relationships that are currently under negotiation.
“From the day that we created our first medicated elixirs, we have known that as an industry we have only just begun to tap the very deep health and healing properties of cannabis,” said Tripp Keber, President and CEO of Dixie Elixirs and Red Dice Holdings, LLC. “These three new products open up a world of potential for DixieandMedical Marijuana, Inc. to bring healthy alternatives to millions of patients who might otherwise never experience the tremendous benefits of cannabinoids. This is truly an exciting development for Dixie and we look forward to bringing Dixie Scrips, Dixie DewDrops, and Dixie Botanicals to patients around the country and around the world who are looking for a healthful alternative to mass-produced, man-made pharmaceutical products.”
About Dixie Elixirs
As Colorado's premier THC-infused products company, Dixie Elixirs & Edibles™, based in Denver, COhas been providing alternative medicated relief for patients in Coloradosince 2009. Dedicated to providing the strength, taste and discretion required by medical marijuana patients, Dixie Elixirs & Edibles provide a complete line of smoke-free medical marijuana products including Dixie Elixirs™ medicated beverages, Dixie Edibles™ infused edibles, Dixie Scrips™ cannabis and herb supplement capsules, Dixie Botanicals™ all-natural transdermal topicals, Dixie Dew Drops™ concentrated tinctures, and Dixie Tonics™ medicated energy boosts. Dixie Elixirs & Edibles products are sold through licensed medical marijuana centers in Coloradoin compliance with CO HB 1284. Find out more at DixieElixirs.com.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to theSafeHarborcreated by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and DrugAdministration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
Investor Relations Contact: